Dear Doctors: I had muscle pain and exhaustion for two years, and no one could figure out what was wrong. A rheumatologist recently diagnosed me with fibromyalgia. I would appreciate any information ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

SOLON, Ohio--(BUSINESS WIRE)--Pioneering the frontier of super-pulsed laser technology, Multi Radiance Medical highlights the impact of FibroLux Therapeutic Laser, one of the first and only ...

Please provide your email address to receive an email when new articles are posted on . For millions suffering from fibromyalgia, the relentless cycle of chronic pain, fatigue and inflammation can ...

PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.

Fibromyalgia is a condition that can cause various symptoms involving pain and fatigue. A rheumatologist may treat this condition alongside a full medical team. Members of the treatment team may ...

Aug 15 (Reuters) - The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals' (TNXP.O), opens new tab drug to manage pain related to a type of chronic condition called fibromyalgia, the ...

Tonix Pharmaceuticals Holding Corp.'s key value driver is TNX-102 SL for fibromyalgia, with an FDA decision expected in August 2025; approval could spike shares, and rejection could devastate them.

TONMYA is a unique, non-opioid, once-daily bedtime analgesic that significantly reduces fibromyalgia pain and is generally well-tolerated CHATHAM, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tonix ...